Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases
S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery
JY Yhee, J Im, RS Nho - Journal of clinical medicine, 2016 - mdpi.com
Chronic lung diseases include a variety of obstinate and fatal diseases, including asthma,
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), idiopathic pulmonary …
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), idiopathic pulmonary …
Nanoparticle formulations in pulmonary drug delivery
MM Bailey, CJ Berkland - Medicinal research reviews, 2009 - Wiley Online Library
The advent of nanotechnology has reignited interest in the lungs as a major route of drug
delivery for both systemic and local treatments. The large surface area of the lungs and the …
delivery for both systemic and local treatments. The large surface area of the lungs and the …
Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery—a review
S Gill, R Löbenberg, T Ku, S Azarmi… - Journal of …, 2007 - ingentaconnect.com
The pulmonary route has recently gained momentum as a suitable avenue for drug delivery.
The large alveolar surface area of approximately 75 m2 coupled with the thin epithelial …
The large alveolar surface area of approximately 75 m2 coupled with the thin epithelial …
Inhaled nanoparticles–An updated review
T Praphawatvet, JI Peters, RO Williams III - International journal of …, 2020 - Elsevier
We are providing an update to our previously published review paper on inhaled
nanoparticles, thus updating with the most recent reports in the literature. The field of …
nanoparticles, thus updating with the most recent reports in the literature. The field of …
Nanoparticle-mediated pulmonary drug delivery: a review
M Paranjpe, CC Müller-Goymann - International journal of molecular …, 2014 - mdpi.com
Colloidal drug delivery systems have been extensively investigated as drug carriers for the
application of different drugs via different routes of administration. Systems, such as solid …
application of different drugs via different routes of administration. Systems, such as solid …
Patented therapeutic drug delivery strategies for targeting pulmonary diseases
Introduction: Pulmonary route is one of the preferred routes for the administration of
therapeutically active agents for systemic as well as localized delivery. Chronic obstructive …
therapeutically active agents for systemic as well as localized delivery. Chronic obstructive …
Nanoparticles for drug delivery to the lungs
JC Sung, BL Pulliam, DA Edwards - Trends in biotechnology, 2007 - cell.com
The lungs are an attractive route for non-invasive drug delivery with advantages for both
systemic and local applications. Incorporating therapeutics with polymeric nanoparticles …
systemic and local applications. Incorporating therapeutics with polymeric nanoparticles …
Medical nanoparticles for next generation drug delivery to the lungs
SH van Rijt, T Bein, S Meiners - 2014 - Eur Respiratory Soc
Respiratory diseases are an increasing burden for the ageing population. Although our
understanding of these diseases has improved significantly over the past decades …
understanding of these diseases has improved significantly over the past decades …
Nanomedicine in pulmonary delivery
HM Mansour, YS Rhee, X Wu - International journal of …, 2009 - Taylor & Francis
The lung is an attractive target for drug delivery due to noninvasive administration via
inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action …
inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action …